Back to Search Start Over

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.

Authors :
Koedijk JB
van der Werf I
Penter L
Vermeulen MA
Barneh F
Perzolli A
Meesters-Ensing JI
Metselaar DS
Margaritis T
Fiocco M
de Groot-Kruseman HA
Moeniralam R
Bang Christensen K
Porter B
Pfaff K
Garcia JS
Rodig SJ
Wu CJ
Hasle H
Nierkens S
Belderbos ME
Zwaan CM
Heidenreich O
Source :
Leukemia [Leukemia] 2024 Nov; Vol. 38 (11), pp. 2332-2343. Date of Electronic Publication: 2024 Aug 26.
Publication Year :
2024

Abstract

Because of the low mutational burden and consequently, fewer potential neoantigens, children with acute myeloid leukemia (AML) are thought to have a T cell-depleted or 'cold' tumor microenvironment and may have a low likelihood of response to T cell-directed immunotherapies. Understanding the composition, phenotype, and spatial organization of T cells and other microenvironmental populations in the pediatric AML bone marrow (BM) is essential for informing future immunotherapeutic trials about targetable immune-evasion mechanisms specific to pediatric AML. Here, we conducted a multidimensional analysis of the tumor immune microenvironment in pediatric AML and non-leukemic controls. We demonstrated that nearly one-third of pediatric AML cases has an immune-infiltrated BM, which is characterized by a decreased ratio of M2- to M1-like macrophages. Furthermore, we detected the presence of large T cell networks, both with and without colocalizing B cells, in the BM and dissected the cellular composition of T- and B cell-rich aggregates using spatial transcriptomics. These analyses revealed that these aggregates are hotspots of CD8 <superscript>+</superscript> T cells, memory B cells, plasma cells and/or plasmablasts, and M1-like macrophages. Collectively, our study provides a multidimensional characterization of the BM immune microenvironment in pediatric AML and indicates starting points for further investigations into immunomodulatory mechanisms in this devastating disease.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
1476-5551
Volume :
38
Issue :
11
Database :
MEDLINE
Journal :
Leukemia
Publication Type :
Academic Journal
Accession number :
39187578
Full Text :
https://doi.org/10.1038/s41375-024-02381-w